Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Blood pressure drugs can cause skin lupus, but it improves after stopping the drug. The glycoprotein D vaccine works against genital herpes in some women, and the HPV-16 vaccine reduces HPV-16 infection and related diseases. More frequent light therapy clears psoriasis faster. A cream called imiquimod effectively treats a type of skin cancer. Iron supplements don't necessarily help with chronic hair loss in women.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

Healthy women tend to lose more hair in July and April, and the least in February.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

Telogen Effluvium is a condition causing excessive hair loss due to stress, illness, drugs, or hormonal changes, and can be treated with specific products or naturally resolves after 3-4 years.

Telogen effluvium is a common hair loss condition requiring careful diagnosis and treatment.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Higher levels of ischemia-modified albumin in telogen effluvium patients may indicate oxidative stress.

General anesthesia might be linked to certain types of hair loss, but more research is needed.

COVID-19 may cause hair loss by affecting hair follicles.

The conclusion is that treatments for Telogen Effluvium exist, but standard treatment guidelines are needed.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

Indian dermatologists recommend treating common hair loss with a balanced diet, stress reduction, mild shampoos, and sometimes minoxidil and supplements.

5% topical minoxidil may help reduce hair loss and increase hair growth in telogen effluvium.

Weight loss can cause temporary hair loss, especially in women and older adults.

Heavy metals might contribute to hair loss in Telogen Effluvium.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

CRH can cause hair loss by promoting cell death in hair growth cells.

COVID-19 can cause hair loss in both severe and mild cases, often affecting women.

Telogen effluvium is common after symptomatic COVID-19, especially in young females, and may be linked to nutritional deficiencies.

Dying cells can help with faster healing and new hair growth by releasing a growth-promoting molecule.

Hair graying can be delayed or prevented with antioxidants, lifestyle changes, and genetic therapy.

A new nanozyme using EGCG and L-arginine boosts hair growth by safely increasing beneficial oxidative stress.

The ACTH/MC2R system is crucial for controlling hair growth cycles in mice.

Hair shedding increases at the end of summer due to seasonal changes.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

Almost half of COVID-19 patients in Makkah, Saudi Arabia experienced increased hair loss, especially women and those with chronic diseases.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Reactive oxygen species (ROS) influence hair growth by causing DNA damage, cell death, and changes in immune cells.